HF
OKUR

HRT Financial’s OnKure Therapeutics OKUR Stock Holding History

HRT Financial’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,055
Closed -$153K – 5615
2026
Q1 		$153K Buy
+37,055
New +$114K ﹤0.01% 3261
2024
Q1 		– Sell
-8,735
Closed -$139K – 3236
2023
Q4 		$139K Buy
+8,735
New +$544K ﹤0.01% 1850

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's OKUR Position: Q2 2026 in Review

HRT Financial sold out of OnKure Therapeutics (OKUR) in Q2 2026, closing a stake of 37,055 shares — an estimated $153K sold.

HRT Financial first reported a position in OKUR in Q4 2023 and held it in 2 quarters. The position peaked at $153K in Q1 2026. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • HRT Financial reported no remaining OnKure Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 37,055 OnKure Therapeutics shares in Q2 2026, an estimated $153K.
  • HRT Financial first reported a position in OnKure Therapeutics in Q4 2023 and held it in 2 quarters.
  • HRT Financial's OnKure Therapeutics position peaked at $153K in Q1 2026.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.